National Institute of Allergy and Infectious Diseases (NIAID): HIV Infections trials

The registry lists 728 HIV Infections studies with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor. 9 are open to participants now and 104 have results posted.

Phase 1 327Phase 2 183Phase 3 57Phase 4 7No phase 195(a study in two phases counts in both)

Studies

Page 3 of 8. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Estimating the Incidence of HIV Infection Among Men Who Have Sex With Men in Peru and EcuadorCompletedNCT00279331
• Social and Economic Outcomes of HIV/AIDS Care and Treatment in HIV Infected South African AdultsCompletedNCT00270764
• Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected AdultsCompletedNCT00270218Phase 1
• Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected ChildrenCompletedNCT00260078Phase 1/2
• Directly Observed Therapy for HIV Infected AdolescentsCompletedNCT00259389Not applicable
• Immune System Function Following Vaccination in HIV Infected Children Taking Anti-HIV DrugsCompletedNCT00257127Not applicable
• Controlling Acute or Early HIV Infection With Antiretroviral Drugs, Without a Candidate Vaccine.As Reported Previously, the Candidate Vaccie Was Not Provided by the Maufacturer as PromisedCompletedNCT00238459
• When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)CompletedNCT00234091Phase 3
• Long Term Follow-Up of HIV Infected Patients Who Have Previously Participated in HIV Clinical TrialsCompletedNCT00183287
• Immune Response to a Therapeutic HIV Vaccine Followed by Treatment Interruption in Patients With Acute or Recent HIV InfectionCompletedNCT00183261Phase 2
• Safety of and Immune Response to the Experimental Preventive HIV Vaccine, EP HIV-1090, in Healthy, HIV-1 Uninfected AdultsCompletedNCT00141024Phase 1
• Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected WomenCompletedNCT00125983Phase 2
• HVTN Protocol 204 - A Phase II Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA016-00-VP, Followed by a Multiclade Recombinant Adenoviral Vector HIV-1 Vaccine Boost, VRCHIVADV014-00-VP, in HIV-1 Uninfected Adult ParticipantsCompletedNCT00125970Phase 2
• Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV InfectionCompletedNCT00125099Phase 1/2
• Safety of and Immune Response to an Adenoviral HIV Vaccine (VRC-HIVADV014-00-VP) With or Without a Plasmid HIV Vaccine (VRC-HIVDNA016-00-VP) in HIV Uninfected AdultsCompletedNCT00124007Phase 1
• Safety of and Immune Response to an HIV-1 Vaccine (VRC-HIVDNA016-00-VP) and a Vaccine Booster (VRC-HIVADV014-00-VP) in HIV Uninfected East African AdultsCompletedNCT00123968Phase 1/2
• Safety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their BabiesCompletedNCT00120471Phase 1
• Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected AdultsCompletedNCT00119873Phase 1
• Safety of and Immune Response to an HIV Preventive Vaccine (HIV-1 Gag DNA Alone or With IL-15 DNA) Given With or Without 2 Different Booster Vaccinations in HIV Uninfected AdultsCompletedNCT00115960Phase 1
• Study of an HIV Preventive Vaccine Given With or Without an Adjuvant in HIV Uninfected AdultsCompletedNCT00111605Phase 1
• Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected AdultsCompletedNCT00110578Phase 1
• "Prime-Boost" Vaccine Schedule for Prevention of HIV InfectionCompletedNCT00109629Phase 1
• Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable TherapyCompletedNCT00107549Phase 1
• Interluekin-7 to Treat HIV-Infected People Receiving Antiretroviral TreatmentCompletedNCT00105417Phase 1
• Computer-Generated Vs. Standard Informed Consent for HIV Research StudiesStatus unknownNCT00104559Not applicable
• An Observational Study of People Who Have Recently Been Infected With HIVCompletedNCT00103961
• Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and WomenCompletedNCT00102986Not applicable
• Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant VirusStatus unknownNCT00102934Not applicable
• A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior TherapyCompletedNCT00102206Phase 2
• HIV-1 Vaccine Booster in Previously Immunized Uninfected Adult VolunteersCompletedNCT00102089Phase 1
• Effect of Leflunomide on T Cell Proliferation in HIV-Infected PatientsCompletedNCT00101374Phase 1
• Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected People in Wenxi County, Shanxi Province, ChinaCompletedNCT00100594Not applicable
• Safety, Effectiveness, and Tolerability of Ezetimibe Combined With Statins for the Treatment of High Cholesterol in HIV Infected AdultsCompletedNCT00099684Not applicable
• Safety of Interleukin-7 in HIV Infected People Currently Taking Anti-HIV DrugsCompletedNCT00099671Phase 1
• Anti-HIV Activity and Safety of 3 Different Doses of Mifepristone in HIV Infected PeopleCompletedNCT00099645Phase 1/2
• Safety of and Immune Response to an HIV-1 Vaccine (ALVAC-HIV vCP1521) in Infants Born to HIV Infected MothersCompletedNCT00098163Phase 1
• Collection of Blood Samples From HIV Infected PeopleCompletedNCT00096772
• Effect of an Intrauterine Contraceptive Device (IUD) in HIV Infected WomenCompletedNCT00096694Not applicable
• HIV Assessment in Fuyang, Anhui Province, ChinaCompletedNCT00094354
• Safety of and Immune Response to an HIV-1 Vaccine Boost (VRC-HIVADV014-00-VP) in HIV Uninfected Adults Who Participated in HVTN 052CompletedNCT00091416Phase 1
• Candidate HIV VaccineCompletedNCT00089531Phase 1
• Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected PatientsCompletedNCT00089466Phase 1/2
• Blood Levels of Abacavir in HIV Infected AdolescentsCompletedNCT00087945Not applicable
• Long-term Follow-up of HIV Infected Patients Identified During Early InfectionCompletedNCT00086372
• Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIVCompletedNCT00086359Phase 3
• Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIVCompletedNCT00084058Phase 1/2
• Voluntary HIV Counseling, Testing, and Medication for Pregnant Women to Prevent Mother-to-Child HIV TransmissionCompletedNCT00084045Not applicable
• Anti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIVWithdrawnNCT00084032Not applicable
• Atazanavir/Ritonavir Maintenance TherapyCompletedNCT00084019Not applicable
• Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected AdultsCompletedNCT00083603Phase 1
• Safety and Immunogenicity of an HIV Vaccine in Normal Adult VolunteersCompletedNCT00083330Phase 1
• Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected PatientsCompletedNCT00082498Phase 2
• Safety and Acceptability of PRO 2000 Vaginal Gel in HIV Uninfected Women in IndiaCompletedNCT00081640Phase 1
• Strategies for Delivering Anti-HIV Therapy in South AfricaCompletedNCT00080522Not applicable
• Daclizumab to Treat HIV-Infected PatientsCompletedNCT00080431Phase 1
• Effectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected PatientsCompletedNCT00080106Phase 2
• Increasing Condom Use in People at Risk for HIV InfectionStatus unknownNCT00080093Not applicable
• Directly Observed Therapy in HIV Infected Adolescent Focus GroupsCompletedNCT00079729
• Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected PeopleCompletedNCT00078442Phase 2
• Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in CambodiaWithdrawnNCT00078182Phase 2/3
• Safety of the EnvPro HIV Vaccine in Healthy VolunteersCompletedNCT00076947Phase 1
• Safety and Effectiveness of Administering an HIV Vaccine in the Groin Versus the ArmCompletedNCT00076817Phase 1
• Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their InfantsCompletedNCT00076791Phase 1
• GW873140 to Treat HIV-1 Infected AdultsCompletedNCT00076284Phase 2
• A Study of Acyclovir to Help Prevent HIV Infection in People With Genital HerpesCompletedNCT00076232Phase 3
• A Study of LIPO-5 and ALVAC-HIV (vCP1452) as Possible HIV VaccinesCompletedNCT00076063Phase 1/2
• Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEPCompletedNCT00076037Phase 1
• Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected AdolescentsCompletedNCT00075907Phase 3
• A Study of Male Rectal Samples in Preparation for Future Rectal Microbicide TrialsCompletedNCT00075062
• BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in WomenCompletedNCT00074425Phase 2
• Nevirapine (NVP) Use to Prevent Mother-to-Child Transmission of HIVCompletedNCT00074399Phase 3
• Immune Function of Infants With HIVCompletedNCT00073229
• Safety of and Immune Response to a Combination HIV Vaccine Regimen in HIV Uninfected AdultsCompletedNCT00073216Phase 1
• Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected AdultsCompletedNCT00071851Phase 1/2
• An Electronic Pillbox for People With HIVStatus unknownNCT00071500Phase 1
• Growth Hormone to Increase Immune Function in People With HIVCompletedNCT00071240Phase 2
• Immune Response to Influenza Vaccine in HIV-Infected IndividualsCompletedNCT00069914
• Effect of an Anti-Inflammatory Drug on Gut Mucosa in HIV Infected PatientsCompletedNCT00069498Phase 1
• Resistance to HIV InfectionStatus unknownNCT00069485
• Safety of and Immune Response to an HIV Vaccine (VRC-HIVDNA009-00-VP) Administered With Interleukin-2/Immunoglobulin (IL-2/Ig) DNA Adjuvant in Uninfected AdultsCompletedNCT00069030Phase 1
• HIV Educational Programs for Villagers of Funan County or Yingzhou District, Anhui Province, ChinaWithdrawnNCT00068991Phase 1
• Analysis of Immune Responses to HIV VaccinesCompletedNCT00068978
• Evaluating Immune Function Tests in People With HIVCompletedNCT00067795
• Antiviral Therapy and HIV in the Female Genital TractCompletedNCT00067106
• Safety of AMD070 When Administered Alone or Boosted With Low-Dose Ritonavir in HIV Uninfected MenCompletedNCT00063804Phase 1
• Safety of an Oral HIV Vaccine in HIV Uninfected VolunteersStatus unknownNCT00062530Phase 1
• Daily Nevirapine to Prevent Mother to Infant Transmission of HIVCompletedNCT00061321Phase 3
• The Effect of Alendronate, Calcium, and Vitamin D on Bone Mineral Density in HIV Infected PatientsCompletedNCT00061256Phase 2
• Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected AdultsStatus unknownNCT00061243Phase 1
• Alternative Dosing Strategy for Anti-HIV DrugsCompletedNCT00059384Phase 4
• Male Circumcision and HIV Rates in KenyaCompletedNCT00059371Phase 3
• Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected PatientsCompletedNCT00058734Phase 1
• Tuberculosis in HIV Infected Patients in UgandaCompletedNCT00057421Phase 2
• Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIVCompletedNCT00056797Phase 2
• HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV DrugsCompletedNCT00056758Phase 1
• Determining an Effective Site (Groin Versus Arm) for Giving HIV VaccinesCompletedNCT00056745Phase 1
• Treatment of Acute HIV Infection to Preserve Immune FunctionCompletedNCT00055094
• Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Uninfected AdultsCompletedNCT00054860Phase 1
• Handheld Computers to Improve Adherence to Anti-HIV Drug RegimensCompletedNCT00053443Phase 2
• Using the Drug Thalidomide to Stimulate T Cells in HIV-Infected PeopleCompletedNCT00053430Phase 2